Kyowa Kirin Completes Biopharmaceutical API Manufacturing Facility, Eying Start of Operations from 2016

April 10, 2014
Kyowa Hakko Kirin announced on April 8 that it has completed the construction of the HA4 Plant, a biopharmaceutical active pharmaceutical ingredient (API) manufacturing facility, at its Takasaki Plant in Gunma Prefecture. The company plans to commence its operations in...read more